Inventor · disambiguated record
Pancras C. Wong
Also filed as: WONG PANCRAS C · WONG PANCRAS C B
19 granted patents·4 pending applications·612 citations·filing 1988–2024
96Inventor score
Top patents by PatentIndex Score
23 records- 0198US5138069AAngiotensin II receptor blocking imidazolesDU PONT·Filed 1988·Granted Aug 11, 1992·253 cites·39 claims
- 0296US5155118AMethod and composition for preventing NSAID-induced renal failureDU PONT·Filed 1989·Granted Oct 13, 1992·53 cites·54 claims
- 0393US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0493US5210079ATreatment of chronic renal failure with imidazole angiotensin-II receptor antagonistsDU PONT·Filed 1992·Granted May 11, 1993·62 cites·31 claims
- 0592US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0692US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0790US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 0890US6346517B1Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 12, 2002·20 cites·16 claims
- 0986US9862730B2Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 9, 2018·5 cites·11 claims
- 1086US7018990B2Combination of a factor Xa inhibitor and clopidogrelBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 28, 2006·27 cites·20 claims
- 1185US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1284US5354867AAngiotensin II receptor blocking imidazolesDU PONT·Filed 1993·Granted Oct 11, 1994·29 cites·5 claims
- 1383US6794412B1Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirinBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Sep 21, 2004·13 cites·4 claims
- 1480US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
- 1573US5140037ATreatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonistsDU PONT·Filed 1990·Granted Aug 18, 1992·31 cites·26 claims
- 1669US5492904AComposition of angiotensin-II receptor antagonists and calcium channel blockersDU PONT·Filed 1994·Granted Feb 20, 1996·34 cites·1 claims
- 1766US5254546AFused aryl substituted imidazole angiotensin II receptor inhibitorsDU PONT·Filed 1992·Granted Oct 19, 1993·21 cites·9 claims
- 1854US2002068719A1Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disordersFiled 2001·Application pending·0 cites
- 1950US5137906ATreatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonistsDU PONT·Filed 1990·Granted Aug 11, 1992·16 cites·6 claims
- 2048US5155126ATreatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonistsDU PONT·Filed 1991·Granted Oct 13, 1992·14 cites·6 claims
- 2148US2004067995A1Novel combination of a factor Xa inhibitor and clopidogrelFiled 2003·Application pending·0 cites
- 2243US2008026474A1Assay for differentiating compounds that modulate the extrinsic and/or intrinsic coagulation pathwaysBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2328US5179113ATreatment of central nervous disorders with imidazole compoundsDU PONT·Filed 1991·Granted Jan 12, 1993·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →